En cliquant sur "Accepter", vous acceptez que des cookiessoient stockés sur votre appareil selon notre politique de confidentialité.
Préférences
RefuserAccepter

About us

Founded in 2018 by pharmacoepidemiology experts, ArcaScience bridges cutting-edge AI with pharmaceutical regulatory science. Our mission: revolutionize benefit-risk evaluation and become the world leader in drug decision intelligence.

Book a demo

See how it works

Our vision

The $13 Billion Problem We're Solving

For decades, pharmaceutical teams have relied on fragmented data sources, manual literature reviews, and expensive CRO services to assess benefit-risk—an approach that delays critical decisions, costs millions, and leaves dangerous gaps in evidence.

Complete Benefit-Risk Intelligence. 
In Real Time.

We envision a future where every drug development decision—from preclinical candidate selection to post-marketing surveillance—is informed by complete, transparent benefit-risk intelligence. By replacing legacy service models with AI-powered decision support, we empower pharmaceutical leaders to bring safer, more effective treatments to patients faster.

See our solutions

Our Approach

We Work Together 
to Turn Data Into Better Health

Built by Clinicians, Data Scientists, and Regulatory Experts

ArcaScience isn't a black-box algorithm—it's collaborative intelligence. Our 24 ensemble AI models are trained on the world's largest benefit-risk database (AS Profiling Base 100b®), but data alone isn't enough. Our team includes PhD-level pharmacoepidemiologists who validate every model, ensuring predictions align with medical reality and regulatory standards.

Human Expertise Amplified by AI

Supporting 50+ regulatory submissions across 12 therapeutic areas, including dermatology, immunology, oncology, and rare diseases. Trusted by 20+ blue-chip pharmaceutical clients worldwide.

This hybrid approach delivers insights that are scientifically rigorous, transparent, and actionable. We don't just process data—we translate complexity into clarity, empowering your teams to make confident, evidence-backed decisions.

  • Clinician-trained AI models
  • 100B+ data points synthesized
  • Methodologies grounded in pharmacoepidemiology best practices
  • Collaborative partnerships with research institutions

Compliance by design

Pharmaceutical data demands the highest standards. ArcaScience is architected from the ground up to meet global regulatory requirements, ensuring your benefit-risk analyses are audit-ready and legally defensible.

Meet our team members

Behind every insight is a team of scientists, engineers, and pharmaceutical experts dedicated to transforming drug evaluation. Meet the people building the future of benefit-risk intelligence.

Full name
Job title